One in seven people using GLP-1s are microdosing the medication including celebrities like Andy Cohen and Brooks Nader ...

Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a ...

Experimenters hope to harness the powerful effects of medications such as Ozempic and Wegovy at doses smaller than those studied most.

Dr. Chen says one of the main risks of compounded anti-obesity drugs is the dosing errors. "This may be a result of ...

Many of those who microdose psychedelics do so to feel less anxious or depressed, or enhance mental sharpness and boost ...

Common GLP-1s include semaglutides like Ozempic and Wegovy, and tirzepatides like Zepbound and Mounjaro. These drugs work by mimicking a natural hormone to regulate appetite, blood sugar, and feelings ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like peptide-1 (GLP-1) agonists regain the pounds at a steady rate, returning to ...

People say GLP-1 drugs caused them to relapse on long-dormant eating disorders. NY Post/Don Pearsall Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs.

Telehealth company Hims & Hers unleashed a wild few days in the obesity drug market when it introduced a cheap, compounded version of Novo Nordisk’s new Wegovy pill. It was an audacious attempt for a ...